In addition, polymorphisms of CLU, SORL1, and MS4A4A genes also affect AD-related biomarkers (mainly Aβ, tau, and phosphorylated tau proteins) within the cerebrospinal fluid (Elias-Sonnenschein et al., 2013). Here, MAPT is linked to Alzheimer disease.